{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:02:54Z","timestamp":1790686974053,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.transci.2024.103899","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T17:27:27Z","timestamp":1708104447000},"page":"103899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study"],"prefix":"10.1016","volume":"63","author":[{"given":"Mauricette","family":"Michallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Deloire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcef","family":"Chelgoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Hamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Barraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Labussiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck E.","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hequet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9674","key":"10.1016\/j.transci.2024.103899_bib1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.transci.2024.103899_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41409-020-0977-3","article-title":"Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation","volume":"56","author":"Pagliuca","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.transci.2024.103899_bib3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbmt.2010.05.019","article-title":"Graft-versus-host disease treatment: predictors of survival","volume":"16","author":"Levine","year":"2010","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"issue":"5","key":"10.1016\/j.transci.2024.103899_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/bmt.2010.167","article-title":"Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases","volume":"46","author":"Zohren","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.transci.2024.103899_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbmt.2014.03.016","article-title":"High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients","volume":"20","author":"Al-Kadhimi","year":"2014","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"issue":"3","key":"10.1016\/j.transci.2024.103899_bib6","first-page":"349","article-title":"Extracorporeal photopheresis in acute and chronic graft-versus-host disease","volume":"50","author":"Greinix","year":"2014","journal-title":"Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis"},{"issue":"2","key":"10.1016\/j.transci.2024.103899_bib7","first-page":"157","article-title":"The role of extracorporeal photopheresis in chronic graft-versus-host disease","volume":"52","author":"Radojcic","year":"2015","journal-title":"Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis"},{"issue":"3","key":"10.1016\/j.transci.2024.103899_bib8","first-page":"360","article-title":"A concise review on extracorporeal photochemotherapy: Where we began and where we are now and where are we going!","volume":"52","author":"Perotti","year":"2015","journal-title":"Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis"},{"issue":"2","key":"10.1016\/j.transci.2024.103899_bib9","first-page":"151","article-title":"Extracorporeal photopheresis in prevention and treatment of acute GVHD","volume":"52","author":"Kitko","year":"2015","journal-title":"Transfus Apher Sci: J World Apher Assoc: J Eur Soc Haemapheresis"},{"issue":"3","key":"10.1016\/j.transci.2024.103899_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000508169","article-title":"Extracorporeal photopheresis in graft-versus-host disease","volume":"47","author":"Drexler","year":"2020","journal-title":"Transfus Med hemotherapy: Organ der Dtsch Ges fur Transfus und Immunhamatol"},{"issue":"3","key":"10.1016\/j.transci.2024.103899_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.transci.2024.103899_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2141.2012.09128.x","article-title":"Diagnosis and management of chronic graft-versus-host disease","volume":"158","author":"Dignan","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.transci.2024.103899_bib13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2008-03-141481","article-title":"A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease","volume":"112","author":"Flowers","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2024.103899_bib14","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood.V98.5.1622","article-title":"Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease","volume":"98","author":"Alcindor","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2024.103899_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood-2002-01-0068","article-title":"Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease","volume":"100","author":"Gorgun","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.transci.2024.103899_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/bmt.2014.106","article-title":"Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature","volume":"49","author":"Das-Gupta","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.transci.2024.103899_bib17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bmt.1704984","article-title":"Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors","volume":"35","author":"Foss","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.transci.2024.103899_bib18","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.bbmt.2011.05.004","article-title":"Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study","volume":"17","author":"Greinix","year":"2011","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"issue":"14","key":"10.1016\/j.transci.2024.103899_bib19","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1182\/bloodadvances.2019000145","article-title":"Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD","volume":"3","author":"Jagasia","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.transci.2024.103899_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10428194.2017.1334120","article-title":"Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study","volume":"59","author":"Michallet","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.transci.2024.103899_bib21","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbmt.2019.03.003","article-title":"Changes in immunosuppressive treatment of chronic graft-versus-host disease: comparison of 2 surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland","volume":"25","author":"Wolff","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"11","key":"10.1016\/j.transci.2024.103899_bib22","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41375-022-01701-2","article-title":"Extracorporeal photopheresis in acute and chronic steroid\u2011refractory graft-versus-host disease: an evolving treatment landscape","volume":"36","author":"Greinix","year":"2022","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.transci.2024.103899_bib23","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.transci.2024.103899_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ajh.24976","article-title":"Ruxolitinib-associated infections: a systematic review and meta-analysis","volume":"93","author":"Lussana","year":"2018","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.transci.2024.103899_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.transci.2024.103899_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2024.103899_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715424","article-title":"The pathophysiology and treatment of graft-versus-host disease: lessons learnt from animal models","volume":"12","author":"Teshima","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.transci.2024.103899_bib28","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.bbmt.2014.05.017","article-title":"Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies","volume":"20","author":"Abu-Dalle","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"10.1016\/j.transci.2024.103899_bib29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/bmt.2014.21","article-title":"Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD","volume":"49","author":"Dignan","year":"2014","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"10.1016\/j.transci.2024.103899_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jca.21918","article-title":"Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant","volume":"36","author":"Amat","year":"2021","journal-title":"J Clin Apher"},{"issue":"20","key":"10.1016\/j.transci.2024.103899_bib31","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.2020004823","article-title":"Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial","volume":"135","author":"Jagasia","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2024.103899_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.transci.2024.103899_bib33","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.transci.2024.103899_bib34","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2024.103899_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5045\/br.2014.49.2.100","article-title":"Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis","volume":"49","author":"Malik","year":"2014","journal-title":"Blood Res"},{"issue":"4","key":"10.1016\/j.transci.2024.103899_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41409-020-01122-8","article-title":"Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease","volume":"56","author":"Maas-Bauer","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.transci.2024.103899_bib37","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/s41409-020-0952-z","article-title":"Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level","volume":"55","author":"Modemann","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transci.2024.103899_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/bloodadvances.2018028282","article-title":"Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD","volume":"3","author":"Socie","year":"2019","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.transci.2024.103899_bib39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2017-11-815746","article-title":"alpha(1)-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.","volume":"131","author":"Magenau","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.transci.2024.103899_bib40","doi-asserted-by":"crossref","first-page":"e776","DOI":"10.1016\/S2352-3026(22)00223-X","article-title":"Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice","volume":"9","author":"Malard","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.transci.2024.103899_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720977039","article-title":"Adverse events in second- and third-line treatments for acute and chronic graft-versus-host disease: systematic review","volume":"11","author":"Velickovic","year":"2020","journal-title":"Ther Adv Hematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T12:26:51Z","timestamp":1716035211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1473050224000478"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103899","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103899"}}